Skip to main content

Advertisement

Table 4 Differences between serum FA-ceramide (CER) (nmol/ml) concentrations in children with NAFLD and reference group

From: Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease

Ceramide (FA) NAFLD group M (Q1-Q3) Reference group M (Q1-Q3) p value
CER myristic (C14:0) 1.9 (1.3–2.3) 0.9 (0.7–1.2) < 0.005
CER palmitic (C16:0) 7.8 (6.5–10.0) 5.2 (4.8–6.8) < 0.01
CER palmitoleic (C16:1) 0.9 (0.7–1.1) 0.6 (0.5–0.8) < 0.001
CER stearic (C18:0) 5.2 (4.3–6.8) 4.0 (3.6–4.5) < 0.05
CER oleic (C18:1) 2.9 (2.4–3.7) 2.1 (1.9–2.8) < 0.05
CER linoleic (C18:2) 0.5 (0.1–1.1) 0.2 (0.0–0.7) ns
CER arachidic (C20:0) 0.5 (0.4–0.6) 0.4 (0.4–0.5) ns
CER linolenic (C18:3) 0.3 (0.2–0.4) 0.2 (0.2–0.3) ns
CER behenic (C22:0) 1.6 (1.4–1.7) 1.3 (1.1–1.4) < 0.005
CER arachidonic (C20:4) 0.6 (0.4–0.7) 0.5 (0.4–0.7) ns
CER lignoceric (C24:0) 3.7 (3.0–4.1) 3.0 (2.6–3.3) < 0.01
CER eicosapentaenoic (C20:5) 0.7 (0.7–0.9) 0.8 (0.7–0.9) ns
CER nervinic (C24:1) 2.3 (2.0–2.5) 2.0 (1.9–2.2) ns
CER docosahexaenoic (C22:6) 0.7 (0.6–0.8) 0.7 (0.6–0.8) ns